论文部分内容阅读
目的观察对妊娠糖尿病患者给予门冬胰岛素、黄芪颗粒联合治疗的临床疗效。方法将2015年12月-2016年12月该院妇产科收治的68例妊娠糖尿病患者进行观察,采用随机分组法分为对照组、研究组,每组34例。所有患者均给予基础治疗,对照组同时使用门冬胰岛素治疗,研究组同时给予门冬胰岛素、黄芪颗粒联合治疗,治疗4周,观察两组治疗效果。结果治疗后,研究组餐后2 h血糖(2 hP BG)、空腹血糖(FBG)、糖化血红蛋白(GHb)、总胆固醇(TC)、甘油三酯(TG)水平、血糖达标时间、胰岛素日使用量、低血糖发生率明显低于对照组,研究组餐后2 h尿C肽水平明显优于对照组,各组数据差异有统计学意义(P<0.05)。结论对妊娠糖尿病患者给予门冬胰岛素、黄芪颗粒联合治疗可以快速平稳的降低血糖、血脂水平,减少门冬胰岛素日使用量,疗效安全可靠。
Objective To observe the clinical efficacy of combined administration of insulin aspart and astragalus granules in gestational diabetes mellitus patients. Methods Seventy-six patients with gestational diabetes mellitus admitted from December 2015 to December 2016 in our hospital were divided into control group and study group, 34 cases in each group. All patients were given basic treatment, the control group also used insulin aspart, the study group also given aspartic insulin, astragalus granules combined treatment for 4 weeks, the two groups were treated. Results After the treatment, the levels of 2 hP BG, FBG, GHb, TC, TG, blood glucose level, insulin daily use The incidence of hypoglycaemia was significantly lower in the study group than in the control group at 2 h postprandial diet, with significant difference between the groups (P <0.05). Conclusion Aspartic insulin and astragalus membranaceus combined therapy in gestational diabetes patients can reduce blood glucose and blood lipid levels rapidly and steadily, and reduce the daily dosage of insulin aspart. The curative effect is safe and reliable.